Premier Qatar, Latvian Cancer Centers to Offer Patients Treatment with the CyberKnife® System; Leading Bulgarian Hospital to Provide Treatment with the TomoTherapy® System SUNNYVALE, Calif. , Jan. 14, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the first centers in
Auckland Radiation Oncology Selected the Latest-Generation CyberKnife S7™ System to Deliver Precise Treatments More Quickly, so Patients Can Rapidly Return to the Activities They Enjoy SUNNYVALE, Calif. , Jan. 17, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that
World's Only Robotic Radiation Therapy Device Delivers Extremely Precise Treatments in Just 1 to 5 Out- Patient Sessions SUNNYVALE, Calif. , Sept. 30, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company is expanding its global footprint with the introduction of its
Physicians at Instituto Neurologico de Colombia (INDEC) Can Now Provide Cancer Patients a Pain-Free, Non-Invasive Treatment Option SUNNYVALE, Calif. , Aug. 2, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that doctors at Instituto
Diamond Plus Service Program Offers Consulting & Professional Development Services to Enhance Center Success SUNNYVALE, Calif., Oct 29, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated, a global leader in the field of radiosurgery, announced today expansion of its Diamond service program to
--Purchase of Axeda ServiceLink Solution Enables Fast and Effective Servicing SUNNYVALE, Calif., July 26, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today the launch of the CyberKnife Access((TM)) Remote
SUNNYVALE, Calif. , May 6, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that it has entered into privately negotiated agreements with the holders of its existing 3.75% senior convertible notes due 2022 (the "2022 Notes") to exchange an aggregate of $82.1 million
SUNNYVALE, Calif., May 14 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced it will conduct a live conference call and webcast for investors and analysts to discuss announced amendments to the Company's fiscal third quarter
MADISON, Wis. , Oct. 3, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the CNNC-Accuray joint venture Tomo ® C radiation therapy system for the Type B market has been approved by the Chinese National Medical Products Administration (NMPA).
Interoperability between Brainlab and Accuray planning systems using Snke OS, an enterprise health tech platform SUNNYVALE, Calif. , Oct. 28, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a pioneer in the robotic stereotactic radiosurgery (SRS) field announced today a collaboration with
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
